Central nervous system effects of the essential oil of the leaves of Alpinia zerumbet in mice

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 11, 2009, Pages 1521-1527

  De Araújo, Fernanda Yvelize Ramos ^a   Silva, Maria Izabel Gomes ^a   Moura, Brinell Arcanjo ^a   De Oliveira, Gersilene Valente ^a   Moreira Leal, Luzia Kalyne A ^a   Vasconcelos, Silvânia Maria Mendes ^a   Viana, Glauce Socorro Barros ^a   De Moraes, Manoel Odorico ^a   De Sousa, Francisca Cléa Florenço ^a   Macêdo, Danielle Silveira ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Alpinia speciosa; Alpinia zerumbet; Apomorphine induced stereotypy; Central nervous system; Depressant

Indexed keywords

ALPINIA ZERUMBET EXTRACT; APOMORPHINE; DIAZEPAM; ESSENTIAL OIL; HALOPERIDOL; IMIPRAMINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALPINIA ZERUMBET; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CATALEPSY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; LOCOMOTION; MAZE TEST; MEDICINAL PLANT; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PLANT LEAF; STEREOTYPY;

ALPINIA; ANIMALS; ANTIPSYCHOTIC AGENTS; ANXIETY; APOMORPHINE; BEHAVIOR, ANIMAL; CATALEPSY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; MAZE LEARNING; MICE; MOTOR ACTIVITY; OILS, VOLATILE; PLANT EXTRACTS; TAIL;

EID: 75749110611     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp/61.11.0012     Document Type: Article

References (39)

1. Hong X et al. Labdane diterpenes from Alpinia zerumbet. Phytochemistry 1996; 42: 149-151.
2. Almeida ER. Plantas medicinais brasileiras - Conhecimentos populares e científicos. São Paulo: Hemus, 1993.
3. Cruz GL. Livro Verde das Plantas Medicinais e Industriais do Brasil. Belo Horizonte: Helmus Ed, 1965.
4. Mendonça VL et al. Pharmacological and toxicological evaluation of Alpinia speciosa. Mem Inst Oswaldo Cruz 1991; 86: 93-97.
5. Lahlou S et al. Cardiovascular effects of the essential oil of Alpinia zerumbet leaves and its main constituent, terpinen-4-ol, in rats: role of the autonomic nervous system. Planta Med 2002; 68: 1097-1102.
6. Leal-Cardoso JH et al. Effects of essential oil of Alpinia zerumbet on the compound action potential of the rat sciatic nerve. Phytomedicine 2004; 11: 549-553.
7. De Araújo PF et al. Antinociceptive effects of the essential oil of Alpinia zerumbet on mice. Phytomedicine 2005; 12: 482-486.
8. Bezerra MA et al. Myorelaxant and antispasmodic effects of the essential oil of Alpinia speciosa on rat ileum. Phytother Res 2000; 14: 549-551.
9. Masuda T et al. Isolation and structure determination of new antioxidative ferulic acid glucoside esters form the rhizome of Alpinia speciosa, a Zingiberaceae plant used in Okinawan food culture. J Agric Food Chem 2000; 48: 1479-1484.
10. Morita M et al. Structure and spasmolytic activities of derivatives form sesquiterpenes of Alpinia speciosa and Alpinia japonica. Chem Pharm Bull 1996; 44: 1479-1484.
11. Mpalantinos MA et al. Biologically active flavonoids and kava pyrones form the aqueous extract of Alpinia zerumbet. Phytother Res 1998; 12: 442-444.
12. Kumar V. Potential medicinal plants for CNS disorders: an overview. Phytother Res 2006; 20: 1023-1035.
13. Jarema M. Herbal drug treatment. Neuro Endocrinol Lett 2008; 23: 29.
14. Olfert ED et al. eds. Guide to the Care and Use of Experimental Animals, volume 1, 2nd edn. Canadian Council on Animal Care: 1993.
15. Craveiro AA et al. A simple and inexpensive steam generator for essential oil extractions. J Chem Ed 1976; 53: 652.
16. Adams RP. Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy. Carol Stream, Illinois: Allured Publishing Corporation, 1995.
17. Alencar JW et al. Kovats indexes as a pre-s routine in mass spectra library search of volatiles. J Nat Prod 1984; 47: 890-892.
18. Archer J. Tests for emotionality in rats and mice: a review. Anim Behav 1973; 21: 205-235.
19. Costall B, Naylor RJ. On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity. Psychopharmacologia 1974; 34: 233-241.
20. Meller CA et al. The bombesin/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK-801-induced stereotypy in mice. Peptides 2004; 25: 585-588.
21. Picada JN et al. An oxidized form of apomorphine fails to induce stereotypy. Schizophr Res 2003; 63: 199-200.
22. Battisti JJ et al. NMDA antagonists block expression of sensitization of amphetamine- and apomorphine-induced stereotypy. Pharmacol Biochem Behav 2000; 67: 241-246.
23. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987; 92: 180-185.
24. Cryan JF et al. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002; 23: 238-245.
25. Porsolt RD et al. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327-336.
26. Natesan S et al. Amisulpride the 'atypical' atypical antipsychotic: comparison to haloperidol, risperidone and clozapine. Schizophr Res 2008; 105: 224-235.
27. Steru L et al. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985; 85: 367-370.
28. Gispen WH, Isaacson RL. ACTH-induced excessive grooming in the rat. Pharmacol Ther 1981; 12: 209-246.
29. Drago F et al. The expression of neuropeptide-induced excessive grooming behavior in dopamine D1 and D2 receptor-deficient mice. Eur J Pharmacol 1999; 365: 125-131.
30. Zuo J et al. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 387-397.
31. Ellenbroek BA, Cools AR. Apomorphine susceptibility and animal models for psychopathology: genes and environment. Behav Genet 2002; 32: 349-361.
32. Randrup A, Munkvad I. Pharmacology and physiology of stereotyped behavior. J Psychiatr Res 1974; 11: 1-10.
33. Sanberg PR. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature 1980; 284: 472-473.
34. Pellow S et al. Validation of open : closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14: 149-167.
35. Borsini F, Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 1988; 94: 147-160.
36. Steru L et al. The automated tail suspension test: a computerized device which differentiates psychotropic drugs. Prog Neuropsychopharmacol Biol Psychiatry 1987; 11: 659-671.
37. De Sousa DP et al. Evaluation of the anticonvulsant activity of terpinen-4-ol. Z Naturforsch C 2009; 64: 1-5.
38. Santos FA, Rao VS. Antiinflammatory and antinociceptive effects of 1,8-cineole, a terpenoid oxide present in many plant essential oils. Phytother Res 2000; 14: 240-244.
39. Zhang XY et al. The effect of extract of ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia. J Clin Psychopharmacol 2001; 21: 85-88.